Consensus ADMA Biologics, Inc.

Equities

ADMA

US0008991046

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
9.55 ^USD	+0.74%		-0.10%	+111.28%

May. 10	HC Wainwright Adjusts ADMA Biologics' Price Target to $10 From $7.50, Maintains Buy Rating	MT
May. 10	Cantor Fitzgerald Adjusts ADMA Biologics' Price Target to $10 From $8, Maintains Overweight Rating	MT

Evolution of the average Target Price on ADMA Biologics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c57310aa.5z5Kd84t5ZIXVJQMlJa3Kc6W30lh6GDZooHLZ7K8jgQ.hEQtFJlpj9l2H8Vj0t3-GazslH8EolOt9uWNJvXt-WyWDwc5ilusy0IbpA~678cb18e2c0c3885e4638c881391e95c

Analyst Recommendations on ADMA Biologics, Inc.

HC Wainwright Adjusts ADMA Biologics' Price Target to $10 From $7.50, Maintains Buy Rating	May. 10	MT
Cantor Fitzgerald Adjusts ADMA Biologics' Price Target to $10 From $8, Maintains Overweight Rating	May. 10	MT
HC Wainwright Adjusts ADMA Biologics Price Target to $7.50 From $6, Maintains Buy Rating	Mar. 26	MT
Mizuho Adjusts Price Target on ADMA Biologics to $10 From $9, Maintains Buy Rating	Mar. 01	MT
Mizuho Securities Raises Price Target on ADMA Biologics to $9 From $7, Maintains Buy Rating	Jan. 22	MT
HC Wainwright Adjusts Price Target on ADMA Biologics to $6 From $5, Maintains Buy Rating	Jan. 09	MT
Raymond James Adjusts Price Target on ADMA Biologics to $6 From $5, Maintains Strong Buy Rating	23-08-10	MT
HC Wainwright Adjusts Price Target on ADMA Biologics to $5 From $4.50, Maintains Buy Rating	23-08-10	MT
HC Wainwright Ups Price Target on ADMA Biologics to $4.50 From $4, Keeps Buy Rating	23-01-03	MT
Mizuho Securities Adjusts Price Target on ADMA Biologics to $6 From $5, Maintains Buy Rating	22-11-10	MT
Mizuho Securities Starts ADMA Biologics at Buy With $5 Price Target	22-10-13	MT
HC Wainwright Adjusts ADMA Biologics' Price Target to $4 from $6, Keeps Buy Rating	22-07-25	MT
ADMA Biologics Q3 Loss Narrows as Sales Rise; Raymond James Lifts Stock Rating -- Shares Soar Thursday Afternoon	21-11-11	MT
Raymond James Upgrades ADMA Biologics to Strong Buy From Outperform; Keeps Price Target at $5	21-11-11	MT
Cantor Fitzgerald Starts ADMA Biologics at Overweight With $4.50 Price Target	21-11-09	MT
ADMA BIOLOGICS : Chardan Suspends Coverage on ADMA Biologics at Buy Rating With $11 Price Target	21-08-02	MT
ADMA BIOLOGICS : HC Wainwright Adjusts ADMA Biologics' Price Target to $7 From $10, Keeps Buy Rating	21-07-06	MT
DJ Industrial : Stocks Fall Ahead of Fed Rate Decision	21-04-28	MT
Midday Report: Wall Street Falls Ahead of Fed Rate Decision	21-04-28	MT
DJ Industrial : Wall Street Subdued Pre-Open, Fed Rate Decision in Focus	21-04-28	MT
ADMA BIOLOGICS : Raymond James Adjusts ADMA Biologics' Price Target to $6 From $7, Maintains Outperform Rating	21-03-26	MT
ADMA BIOLOGICS : HC Wainwright Adjusts ADMA Biologics' Price Target to $11 From $12, Keeps at Buy	21-01-04	MT
ADMA BIOLOGICS : Oppenheimer Adjusts ADMA Biologics' Price Target to $4 From $6, Maintains Outperform Rating	20-11-06	MT